piR-34379 inhibits bladder cancer progression and reverses cisplatin resistance by downregulating ACAT2-mediated PKM2 lactylation
Cellular Signalling
· Elsevier
Аннотация
Publication date: February 2027 Source: Cellular Signalling, Volume 150 Author(s): Suyuelin Huang, Yuxiao Li, Yuchen Shi, Fenghao Zhang, Dingheng Lu, Kai Yu, Jiawei Zhang, Jihuan Yuan, Xiao Wang, Xueyou Ma, Jiangfeng Li, Jiazhu Sun, Ben Liu
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Клеточная биология»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
piR-34379 inhibits bladder cancer progression and reverses cisplatin resistance by downregulating ACAT2-mediated PKM2 lactylation. // Cellular Signalling. – URL: https://www.sciencedirect.com/science/article/pii/S0898656826006388?dgcid=rss_sd_all
piR-34379 inhibits bladder cancer progression and reverses cisplatin resistance by downregulating ACAT2-mediated PKM2 lactylation. Cellular Signalling. https://www.sciencedirect.com/science/article/pii/S0898656826006388?dgcid=rss_sd_all
“piR-34379 inhibits bladder cancer progression and reverses cisplatin resistance by downregulating ACAT2-mediated PKM2 lactylation.” Cellular Signalling.
@article{article40111,
title = {piR-34379 inhibits bladder cancer progression and reverses cisplatin resistance by downregulating ACAT2-mediated PKM2 lactylation},
journal = {Cellular Signalling},
url = {https://www.sciencedirect.com/science/article/pii/S0898656826006388?dgcid=rss_sd_all}
}